ERX - A thread for everyone

The directors have produced forecasts for 12 months from the date of signing
these accounts. These forecasts show a requirement for a #1m fundraising in
April 2007, in order to continue scientific and product development.



The directors have entered into discussions with brokers who have indicated that
the funds will be able to be raised, but, as with any future fundraising, the
outcome is uncertain.

Also MGI pharma's trials of ZYC300 should end in April 2007